دوره 11، شماره 4 - ( 8-1402 )
جلد 11 شماره 4 صفحات 0-0 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Parastesh M, Aria B. The Role of Moderate-intensity Continuous Exercise in Reducing Liver Enzyme Levels and Lipid Dysregulation in Platinol-induced Rats. Res Mol Med (RMM) 2023; 11 (4)
URL: http://rmm.mazums.ac.ir/article-1-554-fa.html
URL: http://rmm.mazums.ac.ir/article-1-554-fa.html
The Role of Moderate-intensity Continuous Exercise in Reducing Liver Enzyme Levels and Lipid Dysregulation in Platinol-induced Rats. Research in Molecular Medicine. 1402; 11 (4)
چکیده: (509 مشاهده)
Background: Platinum-based chemotherapy, a cornerstone in cancer treatment, can induce hepatotoxicity. Exercise can mitigate adverse effects of chemotherapy, including liver damage. This study aimed to investigate the protective effects of moderate-intensity continuous training (MICT) on liver function and lipid metabolism in rats induced with Platinol.
Materials and Methods: Twenty-four male Sprague-Dawley rats were randomly divided into four groups: A healthy control group, a platinol-injected control group, a MICT group, and a platinolinjected group with MICT. Serum liver enzymes alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate aminotransferase (AST) and lipid profiles were measured after 10 weeks of training or platinol injection.
Results: MICT significantly reduced serum levels of AST, ALT and ALP in platinol-induced rats, comparable to healthy controls. Additionally, MICT improved lipid profiles by reducing cholesterol, triglycerides, and low-density lipoprotein cholesterol while increasing high-density lipoprotein cholesterol (HDL).
Conclusion: MICT may be a promising intervention to mitigate platinum-induced liver toxicity and dyslipidemia. Further research is warranted to explore the potential clinical implications of these findings for cancer patients undergoing chemotherapy.
Materials and Methods: Twenty-four male Sprague-Dawley rats were randomly divided into four groups: A healthy control group, a platinol-injected control group, a MICT group, and a platinolinjected group with MICT. Serum liver enzymes alkaline phosphatase (ALP), alanine transaminase (ALT), aspartate aminotransferase (AST) and lipid profiles were measured after 10 weeks of training or platinol injection.
Results: MICT significantly reduced serum levels of AST, ALT and ALP in platinol-induced rats, comparable to healthy controls. Additionally, MICT improved lipid profiles by reducing cholesterol, triglycerides, and low-density lipoprotein cholesterol while increasing high-density lipoprotein cholesterol (HDL).
Conclusion: MICT may be a promising intervention to mitigate platinum-induced liver toxicity and dyslipidemia. Further research is warranted to explore the potential clinical implications of these findings for cancer patients undergoing chemotherapy.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
